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Malignant cancer cells utilize their intrinsic migratory ability to invade adjacent tissues and the vasculature, and ultimately to metastasize. Cell
migration is the sum of multi-step processes initiated by the formation of membrane protrusions in response to migratory and chemotactic stimuli.
The driving force for membrane protrusion is localized polymerization of submembrane actin filaments. Recently, several studies revealed that
molecules that link migratory signals to the actin cytoskeleton are upregulated in invasive and metastatic cancer cells. In this review, we
summarize recent progress on molecular mechanisms of formation of invasive protrusions used by tumor cells, such as lamellipodia and
invadopodia, with regard to the functions of key regulatory proteins of the actin cytoskeleton; WASP family proteins, Arp2/3 complex, LIM-
kinase, cofilin, and cortactin.
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Cell migration is required for many biological processes,
such as embryonic morphogenesis, immune surveillance, and
tissue repair and regeneration. Aberrant regulation of cell
migration drives progression of many diseases, including
cancer invasion and metastasis [1–3]. Therefore, understand-
ing the fundamental mechanisms of cell migration is critical
for our understanding of both basic biology and the pathology
of disease. Cell migration is a highly integrated multistep
process that is initiated by the protrusion of the cell membrane
[4]. Protrusive structures formed by migrating and invading
cells were termed filopodia, lamellipodia, and invadopodia/
podosomes, dependently on their morphological, structural,
and functional characters (Fig. 1). Formation of these
structures is driven by spatially- and temporally-regulated
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doi:10.1016/j.bbamcr.2006.07.001Cell migration and invasion are triggered by a number of
chemoattractants. Upon binding to cell surface receptors, these
chemoattractants stimulate intracellular signaling pathways that
regulate reorganization of the actin cytoskeleton. To date,
several important proteins that mediate the signaling pathways
have been identified as overexpressed in several types of
cancers [2] and in the subpopulation of invasive tumor cells in
breast tumors [6]. Among them, Wiskott–Aldrich syndrome
protein (WASP) family proteins/Arp2/3 complex, LIM-kinase/
cofilin, and cortactin pathways have been studied extensively
due to their apparent importance in cell migration and invasion
(Fig. 2). In this review, we summarize recent findings on
molecular mechanisms underlying formation of membrane
protrusions and functions of these proteins particularly in cancer
cell migration, invasion, and metastasis.
2. Lamellipodia generate the driving force for cell
migration
Lamellipodia are flat, sheet-like membrane protrusions
formed at the leading edge of migrating cells. It is generally
believed that lamellipodia have a major role in driving cell
migration by attaching to the substrate and generating force to
Fig. 1. Cell migration and membrane protrusions in different environments. Cells migrating on 2D substrates form membrane protrusions called filopodia and
lamellipodia at the leading edge. Cells entering into and migrating in a dense rigid ECM in 3D, such as tumor cells on top of a thick ECM and those found around
blood vessels, need to form membrane protrusions at the invading front, such as invadopodia and podosomes that have an ECM remodeling activity. Formation of
these structures is driven by localized actin polymerization. Proteins involved in formation of these protrusions are often upregulated in malignant cancer cells and
associated with increased cell motility and invasion. Arrows indicate the direction of cell migration.
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cells crawling on extracellular matrix (ECM) fibers toward
blood vessels in primary tumors extend pseudopodia (function-Fig. 2. Model for lamellipodium and invadopodium/podosome formation. (A) 1:
machinery for barbed end formation including cofilin is inactive. 2: Chemoattractan
to severing of pre-existing actin filaments and formation of free barbed ends from
and sets the direction of cell migration. 3: Arp2/3 complex and WAVEs associate w
and the branched actin network. Subsequently, the branched actin filaments are sta
leads to cell movement. (B) 1: Invadopodium/podosome formation is triggered by N
of growth factor receptor and integrin signaling. 2: This precursor is stabilized by
actin network by cofilin. 3: Anchored precursor then gathers matrix-degrading pro
cortactin, and cofilin continue to induce actin polymerization to maintain the struc
filaments are not yet determined in invadopodia/podosomes. (C) The signaling p
response to growth factor stimulation. Molecules discussed in this review are highally equivalent to lamellipodia) that attach to the fibers at the
migration front [7]. Lamellipodia contain dendritic arrays of
actin filaments and the molecular machinery that controlsUnstimulated cells have non-polarized cell morphology in which molecular
t stimulation induces local activation of cofilin at the leading edge, which leads
which new actin filaments are assembled. This initiates membrane protrusions
ith newly formed actin filaments and induce formation of further barbed ends
bilized by cortactin. This strengthens the protrusive force of lamellipodia and
-WASP/WASP, Arp2/3 complex and cortactin, probably by coupled activation
further recruitment of invadopodium/podosome components and formation of
teinases to degrade ECM and protrude into matrix. N-WASP/Arp2/3 complex,
tural core. In contrast to lamellipodia, the structure and organization of actin
athways leading to protrusion of lamellipodia and invadopodia/podosomes in
lighted in red.
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filaments [8]. Filopodia are thin, finger-like projections consist-
ing of bundled, crosslinked actin filaments and they are also
observed at the migrating front of cells [9]. Although filopodia
are proposed to sense external cues to set the direction of cell
migration, the exact role of filopodia is still not understood.
Therefore, we will not discuss filopodia in this review.
The protrusion of lamellipodia is initiated by localized
polymerization of actin, and this requires generation of free
barbed ends of actin filaments at the leading edge. There are
three major mechanisms for generation of free barbed ends: (1)
de novo nucleation by Arp2/3 complex and formins, (2) severing
of pre-existing actin filaments by cofilin, and (3) uncapping of
barbed ends on pre-existing actin filaments [10,11]. Many
chemotactic factors have been shown to stimulate intracellular
signaling pathways, which lead to barbed end formation through
these mechanisms. Among them, EGF is a critical chemotactic,
lamellipodia-inducing factor for breast cancer cells and activa-
tion of EGF signaling pathway is directly correlated with
increased invasion, intravasation, and metastasis [12]. Gene
expression analyses revealed that components involved in
lamellipodium formation downstream of EGF signaling path-Table 1
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cofilin pathways, are upregulated in invasive breast cancer cells
[6]. Other studies also identified these proteins as overexpressed
in several types of cancers (Table 1). These proteins coordinately
regulate the formation of lamellipodia, thereby regulating
migration and invasion of cancer cells.
3. Invadopodia/podosomes promote cell migration through
ECM
To migrate through a dense barrier of ECM, cells need to
degrade and remodel ECM structures [13]. Invadopodia are
ventral membrane protrusions with an ECM degradation
activity formed by highly invasive cancer cells on thick
physiological substrates [14]. Invadopodia are composed of a
variety of proteins, such as actin and actin regulatory proteins,
adhesion molecules, membrane remodeling and signaling
proteins, and matrix degradation enzymes. Among them, N-
WASP and cortactin are essential components that compose
core structure of invadopodia and these proteins are upregulated
in malignant cancer cells (Table 1). Carcinoma cells seem to
utilize invadopodia type protrusions to migrate and invadeactin in cancer cell migration, invasion, and metastasis
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metastasis [3,7]. Podosomes are similar to invadopodia in their
appearance and molecular composition. Classic podosomes are
formed by cell types of monocytic origin, such as macrophages,
dendritic cells, and osteoclasts. Podosome-like structures have
also been reported in other cell types, including smooth muscle
and endothelial cells [15,16]. Importantly, the formation of
podosomes (sometimes interchangeably called invadopodia) is
induced by oncogenic transformation of fibroblasts by v-Src,
suggesting the importance of these structures in oncogene-
driven cell motility and invasion. Podosomes had been
considered as dynamic adhesion sites required for chemotactic
cell migration. Recent studies, however, demonstrated that
podosomes are capable of degrading ECM of physiological
substrates [17–20]. Therefore, invadopodia and podosomes are
proposed to have the same physiological function, i.e.,
remodeling of ECM structures, even though their morphologi-
cal appearance may vary among cell types.
Accumulating evidence suggests that the interaction between
tumor cells and the stromal compartment, including stromal
cells, ECM, chemokines, and blood vessels, have a major role in
cancer progression. For example, macrophages within primary
tumors facilitate tumor progression and metastasis [21,22].
Invasive carcinoma cells and tumor-associated macrophages
have been shown to interact through a CSF-1/EGF paracrine
loop, which enhance migration, invasion, and intravasation of
carcinoma cells [23,24]. Since EGF and CSF-1 stimulate the
formation of invadopodia in carcinoma cells and podosomes in
macrophages, respectively [20,25], the CSF-1/EGF paracrine
loop is likely to promote matrix remodeling required for tumor
invasion. Angiogenic chemokines that exist in tumor stroma,
such as VEGF, TNFα, and TGFβ, were also shown to induce
the formation of podosomes in endothelial cells [19,26]. Given
that angiogenesis requires extensive remodeling of ECM
surrounding capillaries, podosomes formed by endothelial
cells may be involved in this process.
4. WASP family proteins and Arp2/3 complex
The WASP family consists of five members in mammalian
cells, including WASP, N-WASP (neural WASP), WAVE1
(WASP family verprolin homologous protein 1), WAVE2, and
WAVE3, which can be divided into two subgroups, WASP/N-
WASP and WAVEs [27,28]. WASP family proteins integrate
multiple upstream signals to induce actin polymerization through
the Arp2/3 complex, an activator of actin filament nucleation and
branching [29]. Several lines of evidence indicate that these
proteins are necessary for cell protrusive activity associated with
cell migration and invasion. Moreover, the expression of WASP
family proteins and Arp2/3 complex has been associated with
malignant phenotypes of cancer cells, indicating the importance
of these proteins in cancer cell migration and invasion [6,30–33].
4.1. WASP and N-WASP in invadopodium/podosome formation
WASP and N-WASP share functional domains that interact
with upstream regulators, such as Cdc42, SH3 domain-containing proteins (e.g. Nck and Grb2), and phosphoinosi-
tides. WASP and N-WASP are also regulated through
phosphorylation by Src family kinases. WASP is expressed
exclusively in hematopoietic cells, while N-WASP is ubiqui-
tously expressed and abundant in brain. N-WASP was
originally implicated in filopodium formation downstream of
Cdc42, a potent inducer of filopodia [34], while N-WASP may
not be involved in the formation of lamellipodia in
mammalian cells [35]. N-WASP was shown to be necessary
for the invasion of epithelial cells into 3D collagen gels and to
localize at the invasion front [36], suggesting that N-WASP is
involved in formation of invasive membrane protrusions.
Indeed, several studies recently revealed that WASP and N-
WASP have a pivotal role in formation of matrix-degrading
structures, podosomes/invadopodia.
N-WASP and Arp2/3 complex localize at invadopodia in
highly metastatic MTLn3 rat mammary adenocarcinoma cells
[25] and the activation of N-WASP was observed at
invadopodia actively degrading ECM [37]. Knockdown of
either N-WASP, or its upstream and downstream effectors,
including Nck1, Cdc42, WIP (WASP-interacting protein), and
Arp2/3 complex, suppressed invadopodium formation and
matrix degradation activity in MTLn3 cells [25]. These results
demonstrate that the N-WASP signaling pathway is necessary
for invadopodium formation in carcinoma cells. Consequently,
over expression or increased activity of N-WASP is likely to
promote cancer cell invasion and metastasis. N-WASP is also
involved in podosome formation in non-hematopoietic and non-
cancer cells, including epithelial cells, endothelial cells, and v-
Src transformed fibroblasts [17,19,38]. Similar to N-WASP,
WASP is an essential component of podosomes in hematopoie-
tic cells, such as macrophages and dendritic cells. These cell
types derived from Wiskott–Aldrich syndrome patients, which
is caused by mutation in the gene encoding WASP, are unable to
form podosomes [39,40]. Therefore, WASP and N-WASP are
involved in formation of podosomes and invadopodia in diverse
cell types.
The precise function of WASP/N-WASP in invadopodium/
podosome formation remains to be determined. Because these
structures are shown to require dynamic rearrangement and
continuous assembly of actin filaments [41], WASP/N-WASP
may contribute to these processes by inducing actin filament
nucleation through activation of theArp2/3 complex. In addition,
since WASP and N-WASP have been involved in endocytotic
and phagocytotic processes [42,43], these proteins may promote
internalization of degraded matrix components and/or recycling
of components of invadopodia/podosomes, such as adhesion
molecules and membrane type matrix metalloproteinases.
4.2. WAVEs in lamellipodium formation and more
The function of WAVEs in lamellipodium and membrane
ruffle formation is well established. Although WAVEs bind to
several signaling proteins and phosphoinositides, they are
primarily regulated by Rac, a Rho family small GTPase,
indirectly through intermediate molecules [44–48]. WAVE1
and WAVE3 are rich in brain and also expressed in other tissues
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rich in hematopoietic cells. Studies with fibroblasts derived
form WAVE1 and WAVE2 knockout mice revealed distinct
roles of these proteins in formation of membrane ruffling and
lamellipodia [49–51]. WAVE2 regulates formation of periph-
eral lamellipodia, which are necessary for general cell
migration, while WAVE1 seems to promote formation of dorsal
membrane ruffling and stabilization of peripheral lamellipodia.
Roles of WAVE1 and WAVE2 in cancer cells were studied in
metastatic mouse melanoma cell lines, in which these proteins
are overexpressed as they become metastatic [32]. WAVE2
knockdown by RNAi suppressed membrane ruffling, cell
motility, invasion, and pulmonary metastasis of the melanoma
cells, whereas WAVE1 knockdown had little effect on these
processes. These results indicate that WAVE2 is a primary
regulator of melanoma cell invasion and metastasis. Involve-
ment of WAVE2 in tumor metastasis is also suggested by an
immunohistochemical study showing that coexpression of
WAVE2 and Arp2, a subunit of Arp2/3 complex, is observed
in malignant human lung cancers and correlated with poor
patient outcome [33]. Moreover, Huang et al. reported that
overexpression of motility-related protein-1 (MRP-1/CD9), a
potential suppressor of tumor metastasis that inhibits cancer cell
migration, downregulates WAVE2 expression, which is asso-
ciated with inhibition of lamellipodium formation in HT1080
human fibrosarcoma cells [52]. All these data indicate that
WAVE2 is a key regulator of lamellipodium formation, and
therefore, involved in cancer cell migration. Because WAVE2 is
neither localized at invadopodia nor required for invadopodium
formation in breast cancer cells [25], WAVE2 is likely to
specifically regulate lamellipodium formation-driven general
cell motility.
Although WAVE3 seems to be regulated by similar
molecular mechanisms as WAVE1 and 2 [53], its physiological
role has not been well studied. However, several recent reports
described possible unique functions of WAVE3 in progression
of cancer. Sossey-Alaoui et al. found that the gene encoding
WAVE3 is truncated as a result of a chromosome translocation
in a patient with ganglioneuroblastoma [54]. While it is unclear
whether this truncation causes complete loss of WAVE3
function or results in production of unregulated product, this
finding implicates WAVE3 in tumor progression. In search of
binding partners of WAVE3, it was found that LDOC1 (a
leucine zipper protein, down-regulated in cancer cells) prefer-
entially associates with WAVE3 among WASP family proteins
[55]. Ectopically expressed LDOC1 induces apoptosis of cells
through accumulation of a tumor suppressor p53. Interestingly,
WAVE3 co-expression inhibits the LDOC1-induced apoptosis
by inducing translocation of LDOC1 from the nucleus to the
cytoplasm. Therefore, WAVE3 may negatively regulate the
LDOC1 function, which potentially promotes progression of
tumors. In agreement with this idea, our group reported that
WAVE3 is upregulated in invasive population of MTLn3
carcinoma cells [6]. Notably, WAVE3 expression is hardly
detected in cultured MTLn3 cells [25], suggesting that WAVE3
expression is regulated by the in vivo tumor microenvironment.
Additionally, knockdown studies with adenocarcinoma cellsrevealed that WAVE3 regulates cell migration and invasion
[56,57], and interestingly, expression levels of several matrix
metalloproteinases [56]. Thus, WAVE3 may not only have
expected functions in lamellipodial protrusions, but also have
potential roles in suppression of apoptosis and matrix
metalloproteinase production, both hallmarks of malignant
cancer cells.
5. Cofilin and LIM kinase
Cofilin, which belongs to a family of related proteins [ADF;
Actophorin—A. castellanii; Coactosin—Dictyostelium discoi-
dium; Twinstar—Drosophila melanogaster; unc-60A and unc-
60B—Caenorhabditis elegans; XAC1 and XAC2—Xenopus;
actophorin—Acanthamoeba], as reviewed in [58], is a small
ubiquitous protein (∼19 kDa) that is able to bind both
monomeric and filamentous actin, and is an essential regulator
of actin dynamics at the plasma membrane during cell migration
through its ability to sever actin filaments. Cofilin can be
regulated through different upstream effectors, as reviewed in
[59]; LIM 1 and 2, and TES 1 and 2 kinases phosphorylate
cofilin on the serine 3 residue, thus rendering it inactive [60–
63]; while type 1, 2A, 2B, slingshot, and chronophin
phosphatases dephosphorylate cofilin [64–67]. The protein
phosphatase slingshot and the novel HAD-family phosphatase,
chronophin, have been proposed to be the primary activators of
cofilin by dephosphorylation at serine 3 in a variety of cell types
[64,67]. However, the initiation of cofilin activation in response
to EGF in invasive tumor cells is not coupled to depho-
sphorylation [68]. In addition, cofilin is inhibited when bound to
phosphatydalinositol-4,5-bisphosphate (PIP2) [69,70]. In vivo
studies suggest that PLC-mediated hydrolysis of PIP2 can
release cofilin from this complex thereby activating it [71].
5.1. Cofilin is an essential regulator of cancer cell motility
and invasion
There is little doubt that cofilin activity is required for cell
motility and invasion. Local activation of cofilin by uncaging
induces lamellipodia formation and sets the direction of cell
motility [72]. Inhibition of cofilin activity in carcinoma cells
with either siRNA [73] or expression of constitutively active
LIM kinase domain [74] inhibits cell motility. The suppression
of cofilin expression with siRNA reduces the invasion of
carcinoma cells; in particular cofilin is involved in the
assembly and stability of invadopodia [25]. The over
expression of cofilin by 2–4 fold at the protein level increases
the velocity of cell migration in Dictyostelium [75] and in
human glioblastoma cells [76]. The spontaneous over expres-
sion of cofilin by 2–4 fold at the mRNA level has been
detected in the invasive subpopulation of tumor cells in
mammary tumors [6]. Cofilin is over expressed in the highly
invasive C6 rat glioblastoma cell line [77], and the amount of
phosphorylated, inactive cofilin is decreased in cell lines
derived from T-lymphoma (Jurkat) and carcinomas from the
cervix (HeLa), colon (KM12), liver (HepG2), and kidney
(COS1) [78].
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the stimulation of carcinoma cell motility with EGF, indicating
that the precise balancing of cofilin and LIM kinase activities
is required for stimulated cell migration in tumor cells [71].
The transient presumably occurs as the result of the EGF-
receptor's activation of PLC which releases cofilin from its
inactive complex with PIP2 [71]. Simultaneously, EGF-
receptor activates LIM kinase which limits the spatial and
temporal extent of cofilin activity leading to a localized burst
of actin polymerization seen as a spatially and temporally
discrete transient [68]. The loss of this balance by the hyper
activation of either cofilin or LIM kinase inhibits cell motility
and invasion as shown by the inhibitory effects on cell
motility of huge un-physiological over expression of cofilin
(15 fold) [79], microinjection of constitutively active cofilin
(Mouneimne personal communication) and the expression of
constitutively active LIM kinase domain [74].
The importance of the transient activation of cofilin in
stimulated cell motility has been illustrated by work that has
shown that both PLC and an early actin polymerization
transient at 1 min are required by carcinoma cells for
chemotaxis to a gradient of EGF. In particular, cofilin was
shown to be responsible for this early actin polymerization
transient and to require PLC activation for its activity [71]. In
addition, uncaging of cofilin activity was shown to be
sufficient for initiating both actin polymerization and protru-
sion in vivo, and in defining the direction of cell movement
[72]. These results indicate that spatially and temporally
localized cofilin activity is involved in chemotactic sensing
during invasion [71].
A possible molecular basis for the transient activation of
cofilin is the simultaneous activation of both LIM kinase and
cofilin activities in response to stimulation. The activation of
LIM kinase and phosphorylation of cofilin in response to the
stimulation of cells with growth factors has been observed
[71,80]. However, in some cases the phosphorylation was
assumed, but not shown, to inactivate all cofilin within the
cells and led to the interpretation that cofilin must be inhibited
for cell protrusion and locomotion to occur [80]. This
interpretation is inconsistent with the increases in cofilin
activity observed simultaneously with an increase in cofilin
phosphorylation [68,71,81], and the requirement of cofilin for
cell motility [73]. The interpretation that cofilin must be
inhibited for protrusion and locomotion to occur is also at
odds with the observation that uncaging of cofilin activity in
vivo is sufficient to cause actin polymerization, protrusion and
locomotion [72]. We propose that a more accurate explanation
for these results is that there are two different populations of
cofilin that exist simultaneously in cells during stimulation of
migration: one that is locally activated allowing localized
protrusion, and one that is being phosphorylated to either
recycle cofilin or to confine the cofilin activity to a discrete
location in the cell.
These considerations illustrate the need to measure cofilin
activity in cells during stimulation and migration in order to
interpret the consequences of either cofilin phosphorylation or
dephosphorylation on cofilin function in vivo. Furthermore,additional work is needed to determine the mechanism of
cofilin activation in cells during stimulations that do not
induce the de-phosphorylation of cofilin.
5.2. The function of cofilin in vivo can be explained by a simple
severing mechanism
It is well established that cofilin functions to depolymerize
filaments in cells so that actin can be recycled for another round
of polymerization [73,82]. It is also clear that cofilin can induce
the polymerization of actin in cells by virtue of its severing
activity [71,72]. However, it has been confusing as to whether
the ability of cofilin to depolymerize F-actin is linked to its
severing activity. Kinetic experiments with recombinant cofilin
have been interpreted to mean that cofilin can increase the off
rate of monomers from the pointed end of filaments without
severing [83]. The absence of severing was assumed in these
studies because it was not possible to detect severing activity in
preparations of recombinant cofilin. However, we now know
that it is difficult to detect severing activity in recombinant
cofilin due to the heterogeneity of the recombinant cofilin
molecules compared to native cofilin and that both native and
certain chromatographically purified fractions of recombinant
cofilin show a high specific activity of severing [84]. Cofilin
severing was detected by light microscopy [84–86] and by
intrinsic fluorescence [87]. It is particularly interesting in this
regard that cross linked actin filaments are severed by cofilin at
500 fold lower concentrations of cofilin (K50=9 nM) than
when filaments are in solution (K50=5 μM) [86,88], demon-
strating that cofilin is a much stronger severing protein than
originally suspected. Since the concentration of cofilin in tumor
cells is ∼10 μM [81], these results suggest that only a small
proportion of the cofilin in cells is sufficient to sever the cross
linked actin filaments commonly found in vivo.
These considerations warrant a re-evaluation of certain
assumptions regarding cofilin activity and its mechanism of
depolymerization of F-actin that were made when it was
thought that cofilin does not sever filaments. One assumption is
that cofilin induces the depolymerization of actin filaments
preferentially from their pointed ends. However, when the
number of new pointed and barbed ends produced by cofilin
severing are accounted for in the analysis of cofilin-induced
depolymerization of F-actin, there is no bias of depolymeriza-
tion to the pointed end, i.e. both barbed and pointed ends
contribute to depolymerization, and there is no significant
increase in the off rate of actin monomers from filament ends
[84,87]. That is, the rate constants for actin assembly/
disassembly are constant in the presence of cofilin. All of
these results indicate that both the depolymerization and
polymerization activities of cofilin can be explained by a single
event, cofilin severing of filaments to increase the number of
free pointed and barbed ends.
6. Cortactin
Cortactin is a ubiquitously expressed, actin-binding and
scaffolding protein that plays crucial roles in the regulation of
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processes that require a dynamic actin cytoskeleton, including
cell motility, endocytosis, and intracellular motility of several
pathogens [89,90]. Since human cortactin (EMS1) is upregu-
lated in several types of human cancers as a result of
amplification of chromosome locus 11q13, cortactin is thought
to have a role in tumor malignancy [91,92]. Although, the
11q31 region contains several genes, amplification of both the
EMS1 and CCDN1 gene, which encodes cyclin D1, is often
correlated with tumor progression [91]. This is supported by
studies showing that ectopic overexpression of cortactin
accelerates bone metastasis of breast cancer cells and
intrahepatic metastasis of liver cancer cells [93,94].
Cortactin was originally shown to bind to and crosslink
actin filaments. In addition to these activities, recent
biochemical studies suggest that cortactin also contributes to
the generation of barbed ends and branched arrays of actin
filaments. Cortactin directly activates the actin nucleation
activity of Arp2/3 complex through its N-terminal region,
although the activity is relatively weak when compared with
that of WASP family proteins [95]. Cortactin is also able to
indirectly promote Arp2/3 complex-mediated actin polymer-
ization by binding to N-WASP and activating it [96]. Another
study demonstrated that cortactin also stabilizes branched actin
filaments produced by Arp2/3 complex [97]. Moreover,
cortactin preferentially associates with newly formed, ATP-
bound actin filaments, rather than older ADP-actin filaments
[98]. Taken together, cortactin seems to promote Arp2/3
complex-mediated actin nucleation and stabilizes newly
formed branched actin filaments in the dynamic actin
cytoskeleton.
Cortactin knockdown by RNAi in fibrosarcoma cells results
in impaired cell migration and invasion [98]. These pheno-
types seem to be due to defects in the persistence of
lamellipodial protrusions [98,99]. Importantly, although cor-
tactin localizes at leading edges of lamellipodia, cortactin
knockdown does not inhibit protrusion of lamellipodia per se.
Cortactin knockdown cells show a decrease in barbed end
formation at the leading edge, which is consistent with the
idea that cortactin promotes activation of Arp2/3 complex.
Interestingly, these cells also show a defect in the assembly of
new adhesions in lamellipodia. As Arp2/3 complex has been
shown to associate with vinculin, cortactin may be involved in
actin assembly at adhesion sites [100]. These results indicate
that cortactin is not necessary for the protrusive force of
lamellipodia, but important for proper barbed end formation
and assembly of new adhesions, which are required for
persistence of lamellipodia and cell migration.
In contrast to lamellipodium formation, invadopodium/
podosome formation is clearly dependent on cortactin activity.
In breast cancer cells, cortactin localizes at invadopodia and
injection of an antibody against cortactin inhibits invasive
activity of breast cancer cells [101]. Moreover, cortactin
knockdown by RNAi blocks assembly of invadopodia and
associated matrix degradation activity in breast cancer cells
([102] and H. Yamaguchi, unpublished observations), indicat-
ing that cortactin-mediated invadopodium formation is neces-sary for invasive activity of these cells. Time-lapse imaging of
invadopodium assembly revealed that cortactin induces forma-
tion of actin-rich invadopodial core structures and this precedes
recruitment of matrix proteinases and subsequent matrix
degradation [102]. Podosome formation is also blocked by
down regulation of cortactin in smooth muscle cells and
osteoclasts [103,104]. Since cortactin can bind to several
components of invadopodia/podosomes, such as N-WASP,
WIP, Arp2/3 complex, and dynamin-2, cortactin may cooperate
with these proteins to assemble actin structures at invadopodia
[17,95,105,106]. It is also possible that cortactin is involved in
protein transport from the Golgi apparatus to maintain the
stability and structure of invadopodia, as cortactin–dynamin-2
interaction is necessary for Golgi function and invadopodia
were shown to associate with the Golgi apparatus [107,108].
Cortactin also participates in receptor-mediated endocytosis,
and a recent study showed that this function might contribute to
tumor malignancy. Timpson et al. demonstrated that over-
expression of cortactin in head and neck carcinoma cells is
associated with attenuated ligand-induced down regulation of
EGF receptor, resulting in a sustained activation of the EGF
receptor signaling [109]. As described above, because EGF
receptor signaling has been implicated in invadopodium
formation and is also correlated with increased invasion and
metastasis of carcinoma cells, this observation may add another
role for cortactin in tumor malignancy.
It is not well understood how cortactin activity is regulated in
lamellipodium and invadopodium formation. Cortactin was
originally identified as a major phosphorylated protein in v-Src
transformed cells [110]. Cortactin is also phosphorylated
downstream of many biological stimuli, such as growth factor
stimulation and cell adhesion. Biochemical studies determined
three tyrosine phosphorylation sites by v-Src at the C-terminal
proline-rich region [111]. Because v-Src transformed fibroblasts
form prominent podosomes/invadopodia with matrix degrada-
tion activity and Src activity is necessary for podosome/
invadopodium formation, cortactin phosphorylation by Src
seems to regulate cortactin activity in the formation of these
structures. However, at least in smooth muscle cells, over-
expression of cortactin mutants, which have mutations in the Src
phosphorylation sites, had no effect on formation of podosomes
and these mutant proteins can localize at podosomes [112]. This
result raises the possibility that cortactin phosphorylation has
other functions, such as regulation of stability and/or turnover of
these structures. Cortactin activity may be regulated by other or
additional mechanisms, such as serine phosphorylation by ERK
and cleavage by calpain [110,113]. Further work will be
necessary to clarify the regulatory mechanisms of cortactin
activity in invasive protrusions.
7. Conclusion
Key proteins involved in the actin cytoskeleton described
above are linked to the invasive and metastatic phenotypes of
malignant cancer cells. Recent progress has begun to clarify
molecular functions of each protein in cancer cell migration and
invasion in vitro. However, in vivo, invasive tumor cells often
649H. Yamaguchi, J. Condeelis / Biochimica et Biophysica Acta 1773 (2007) 642–652coordinately overexpress groups of cytoskeletal proteins in
multiple signaling pathways, such as the N-WASP/Arp2/3
complex pathway in conjunction with the LIM kinase/cofilin
pathway, as part of an invasion signature [114]. These pathways
cooperate to amplify the nucleation activity of the Arp2/3
complex: e.g. Arp2/3 complex and cofilin synergize to amplify
dendritic nucleation [115]. Also, cortactin obviously partici-
pates in this process by controlling the stability of branched
actin filaments. Therefore, the next challenge is to understand
how the coordinately regulated pathways of the invasion
signature determine the metastatic phenotype. That is, rather
than analyzing a single protein it will be necessary to analyze
the integrated output of the entire pathway to predict motility
phenotype and metastatic potential. Furthermore, it will also be
important to explore possible master regulators that coordinate
the expression and activity of key actin regulatory proteins.
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